natgillin/translations-raw huggingface dataset:
Sepsis* (often called “blood poisoning”, is a severe infection with whole-body inflammatory response which can lead to death), low platelet count (thrombocytopenia), increase in certain white blood cells (eosinophilia), serious allergic reaction (e.g. hypersensitivity, anaphylactic reaction, drug rash), low blood sugar levels (in diabetic patients), upset stomach, eczema (a skin disorder), arthrosis, inflammation of the tendons, decreased haemoglobin (a blood protein), somnolence.
Sepsa* (pogosto poimenovana tudi “zastrupitev krvi”, je huda okužba, pri kateri pride v vsem telesu do vnetnega odziva in je lahko usodna), majhno število trombocitov (trombocitopenija), povečano število nekaterih belih krvničk (eozinofilija), resne alergijske reakcije (npr. preobčutljivost, anafilaktična reakcija, medikamentni izpuščaj), nizka raven krvnega sladkorja (pri bolnikih s sladkorno boleznijo), želodčne težave, ekcem (kožna bolezen), artroza, vnetje kit, znižana raven hemoglobina (krvne beljakovine), zaspanost.
Sepsis*#
epsa*#
Sepsis*, Pneumonia*, Urinary tract infection,
sepsa*, pljučnica*, okužbe sečil, oralna kandidoza
Sepsis, Abscessb,d,
epsa, abscesb,d,
Sepsis, gastrointestinal candidiasis, urinary tract infection, herpes simplex, herpes zoster
epsa, gastrointestinalna kandidoza, okužba urinarnega trakta, herpes simpleks, herpes zoster
Sepsis, including neutropenic sepsis and septic shock, herpes virus infection, urinary tract infection
epsa, vključno z nevtropenično sepso in septičnim šokom, okužbe s herpesvirusom, okužbe sečil
sepsis, pneumonia, influenza, gastroenteritis, herpes zoster, sinusitis, herpes simplex, oral candidiasis, pyelonephritis, onychomycosis, BK virus infection, respiratory tract infection, candidiasis, rhinitis, cellulitis, wound infection, localised infection, herpes virus infection, fungal infection, fungal skin infection
sepsa, pljučnica, gripa, gastroenteritis, herpes zoster, vnetje sinusov, herpes simpleks, kandidoza ustne votline, pielonefritis, mikoza nohtov, okužba z virusom BK, okužba dihal, kandidoza, vnetje nosne sluznice, celulitis, okužba rane, lokalizirana okužba, okužba z virusom herpesa, glivična okužba, glivična okužba kože
Sepsis, sometimes fatal, has been commonly reported during clinical trials with pemetrexed.
Predhodna kemoterapija ni vključevala pemetrekseda.
Sepsis, Urinary tract
Zelo pogosti
Sepsis, Urinary tract infection, Cellulitis, Tonsillitis, Pharyngitis, Oral candidiasis, Influenza, Gastroenteritis, Fungal infection, Infection, Tooth abscess
sepsa, okužba sečil, celulitis, tonzilitis, faringitis, oralna kandidoza, gripa, gastroenteritis, glivična okužba, okužba, zobni absces
sepsisb, septic shockb, urinary tract infection, respiratory tract infection
sepsab, septični šokb, okužba sečil, okužba dihal
September 2016 (final study report)
september 2016 (končno poročilo o študiji)
September 2018
septembra 2018
Septic shock
eptični šok
Septic Shock (0.2%) (G3/4:0.2%)a
eptični šok (0,2 %) (3./4. stopnje: 0,2 %)a
Septic shock: Cases of septic shock, some of which were fatal, have been uncommonly reported in clinical studies and postmarketing experience, in patients treated either with monotherapy or combination therapy.
Septični šok: Pri bolnikih, zdravljenih z monoterapijo ali kombinirano terapijo, so v okviru kliničnih študij in izkušenj v obdobju trženja občasno poročali o primerih septičnega šoka, od katerih so bili nekateri smrtni.
Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances.
Septikemija in toksemija sta bolezenski stanji, pri katerih bakterije krožijo v krvi in tvorijo škodljive snovi.
Sequential add-on clinical trials
Klinična preskušanja z zaporednim dodajanjem
Serial ECGs in triplicate were collected at baseline and at steady state to evaluate the effect of ponatinib on QT intervals.
Za ovrednotenje učinka ponatiniba na interval QT so opravili po tri zaporedne EKG-meritve ob izhodišču in v stanju dinamičnega ravnovesja.
Serial ECGs in triplicate were collected following a single dose and at steady state to evaluate the effect of crizotinib on QT intervals.
Da bi ovrednotili vpliv krizotiniba na intervale QT, so po enkratnem odmerku zdravila in v stanju dinamičnega ravnovesja posneli zaporedne elektrokardiograme ob uporabi tripletne metode.
Serial ECGs were collected following a single dose and at steady-state to evaluate the effect of ceritinib on the QT interval.
Za ovrednotenje vpliva ceritiniba na interval QT so po odmerjanju enkratnega odmerka in v stanju dinamičnega ravnovesja posneli več zaporednih EKG posnetkov.
Serious able effects might occur (e.g. hepatotoxicity, haematotoxicity or allergic reactions, see below), even if the treatment with leflunomide has been stopped.
Resni neželeni učinki (npr. hepatotoksični in hematotoksični učinki ali alergijske reakcije, glejte spodaj) se lahko pojavijo tudi po prekinitvi zdravljenja z leflunomidom.
Serious acute hypersensitivity (anaphylactic) reactions require immediate emergency treatment.
Pri resnih akutnih preobčutljivostnih (anafilaktičnih) reakcijah je potrebno takojšnje urgentno zdravljenje.
Serious adverse drug reactions include anaphylactic reaction and angioedema which may occur rarely (≥1/10,000 ro <1/1,000), and acute renal failure.
Resni neželeni učinki so anafilaktična reakcija in angioedem, ki sta redka (≥1/10.000 do <1/1.000), in akutna odpoved ledvic.
Serious adverse drug reactions include anaphylactic reaction and angioedema which may occur rarely (≥1/10,000 to < 1/1000), and acute renal failure.
Resni neželeni učinki so anafilaktična reakcija in angioedem, ki sta redka (≥1/10.000 do <1/1.000), in akutna odpoved ledvic.
Serious adverse drug reactions include anaphylactic reaction and angioedema which may occur rarely (≥1/10,000 to <1/1,000), and acute renal failure.
Resni neželeni učinki so anafilaktična reakcija in angioedem, ki sta redka (≥1/10.000 do <1/1.000) in akutna odpoved ledvic.
Serious adverse effects following inadvertent ingestion with the brimonidine component of SIMBRINZA by paediatric subjects have been reported.
Po nenamernem zaužitju učinkovine brimonidin zdravila SIMBRINZA pri otrocih so poročali o pojavu resnih neželenih učinkov.
Serious adverse reactions are known to occur with the concomitant use of SSRIs, SNRIs, tricyclic/ tetracyclic antidepressants and MAO inhibitors.
Znano je, da se pri sočasni uporabi SSRI, SNRI, tricikličnih in tetracikličnih antidepresivov ter inhibitorjev MAO pojavijo hudi neželeni učinki.
Serious adverse reactions have also been reported for Humira.
Poročali so tudi o resnih neželenih učinkih v zvezi z zdravilom Humira.
Serious adverse reactions have been reported with the concomitant use of pethidine and MAO inhibitors.
Ob sočasni uporabi petidina in zaviralcev MAO so poročali o resnih neželenih učinkih.
Serious adverse reactions have been reported with the concomitant use of SSRIs, SNRIs, tricyclic/ tetracyclic antidepressants and MAO inhibitors.
Poročali so o resnih neželenih učinkih ob sočasni uporabi SSRI, SNRI, tricikličnih in tetracikličnih antidepresivov in inhibitorjev MAO.
Serious adverse reactions include:
Med resnimi neželenimi učinki so:
Serious adverse reactions included atrial fibrillation (0.2%).
Resni neţeleni učinek je bila atrijska fibrilacija (0,2 %).
Serious adverse reactions observed in clinical trials of temsirolimus for advanced renal cell carcinoma, but not in clinical trials of temsirolimus for mantle cell lymphoma include: anaphylaxis, impaired wound healing, renal failure with fatal outcomes, and pulmonary embolism.
Resni neželeni učinki, ki so jih opazili v kliničnih preskušanjih temsirolimusa pri napredovalem karcinomu ledvičnih celic, ne pa v preskušanjih temsirolimusa pri limfomu plaščnih celic, so: anafilaksija, slabše celjenje ran, odpoved ledvic s smrtnim izidom in pljučna embolija.
Serious adverse reactions observed in clinical trials of temsirolimus for mantle cell lymphoma, but not in clinical trials of temsirolimus for advanced renal cell carcinoma include: thrombocytopenia, and neutropenia (including febrile neutropenia).
Resni neželeni učinki, ki so jih opazili v kliničnih preskušanjih temsirolimusa pri limfomu plaščnih celic, ne pa v preskušanjih temsirolimusa pri napredovalem karcinomu ledvičnih celic, so: trombocitopenija in nevtropenija (vključno s febrilno nevtropenijo).
Serious adverse reactions of tendon rupture (6 cases), tendonitis (1 case), other ligament injury (2 cases) and complex regional pain syndrome (1 case) related to the medicinal product were reported.
V povezavi z zdravilom so poročali o resnih neželenih učinkih, kot so ruptura kite (6 primerov), tendinitis (1 primer), druge poškodbe ligamentov (2 primera) in sindrom sestavljene regionalne bolečine (1 primer).
Serious adverse reactions uncommonly reported during treatment with bortezomib include cardiac failure, tumour lysis syndrome, pulmonary hypertension, posterior reversible encephalopathy syndrome, acute diffuse infiltrative pulmonary disorders and rarely autonomic neuropathy.
Med zdravljenjem z bortezomibom so občasno poročali o resnih neželenih učinkih – srčno popuščanje, sindrom razpada tumorja, pljučna hipertenzija, sindrom reverzne posteriorne encefalopatije, akutna difuzna infiltracijska pljučna stanja – in redko o avtonomni nevropatiji.
Serious adverse reactions were common (1-10%) and not unexpected in this population.
V tej skupini so bile resne neželene reakcije pogoste (1–10 %) in pričakovane.
Serious adverse reactions were recorded at similar frequencies among patients treated with 2,403 mg/day of Esbriet and placebo in clinical studies.
V kliničnih študijah so bili pri bolnikih, zdravljenih z odmerkom zdravila Esbriet 2403 mg/dan, in bolnikih s placebom resni neželeni učinki zabeleženi približno enako pogosto.
Serious adverse reactions were reported in 3.5% (11/318) and 6.1% (20/328) of the respective group.
O resnih neželenih učinkih so poročali pri
Serious allergic (hypersensitivity) reactions.
Resne alergijske (preobčutljivostne) reakcije.
Serious allergic or skin reactions
Resne alergijske ali kožne reakcije
Serious allergic reaction
Resne alergijske reakcije
Serious allergic reaction (anaphylactic reaction) (not known: frequency cannot be estimated from the available data).
resna alergijska reakcija (anafilaktična reakcija) (pogostnost neznana – pogostnosti iz razpoložljivih podatkov ni mogoče oceniti)
Serious allergic reaction (anaphylactic shock) signs of which may include difficulty breathing, chest pain or chest tightness, and/or feeling dizzy/faint, severe itching of the skin or raised lumps on the skin, swelling of the face, lips, tongue and /or throat, which may cause difficulty in swallowing, collapse
znaki hude alergijske reakcije (anafilaktični šok), ki lahko vključujejo oteženo dihanje, bolečino ali tiščanje v prsih in/ali omotico/omedlevico, hudo srbenje kože ali dvignjene bulice na koži, otekanje obraza, ustnic, jezika in/ali grla, kar lahko povzroči oteženo požiranje in kolaps
Serious allergic reaction (anaphylactic shock) signs of which may include difficulty breathing, chest pain or chest tightness, and/or feeling dizzy/faint, severe itching of the skin or raised lumps on the skin, swelling of the face, lips, tongue and /or throat, which may cause difficulty in swallowing, collapse
znaki hude alergijske reakcije (anafilaktični šok), ki lahko vključujejo oteženo dihanje, bolečino ali tiščanje v prsih, in/ali omotico/omedlevico, hudo srbenje kože ali dvignjene bulice na koži, otekanje obraza, ustnic, jezika in/ali grla, kar lahko povzroči oteženo požiranje in kolaps
Serious allergic reaction (frequency cannot be estimated from the available data) - the signs may include:
Resne alergijske reakcije (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) - znaki lahko vključujejo:
Serious allergic reaction which causes difficulty in breathing or dizziness
resna alergijska reakcija, ki povzroča težave z dihanjem ali omotico,
Serious allergic reaction which causes difficulty in breathing or dizziness
resna alergijska reakcija, ki povzroča težave z dihanjem ali omotico;
Serious allergic reaction which causes difficulty in breathing or dizziness
resna alergijska reakcija, ki povzroči težave z dihanjem ali omotico,
Serious allergic reaction which causes swelling of the face or throat
resna alergijska reakcija, ki povzroča otekanje obraza ali grla;
Serious allergic reaction which causes swelling of the face or throat
resna alergijska reakcija, ki povzroča zatekanje obraza ali grla,
Serious allergic reaction which causes swelling of the face or throat
resna alergijska reakcija, ki povzroča zatekanje obraza ali grla;
Serious allergic reaction which causes swelling of the face or throat
resna alergijska reakcija, ki povzroči otekanje obraza ali grla,
Serious allergic reaction which causes swelling of the face, throat, hand, feet, ankles, or lower legs
resne alergijske reakcije, ki povzročajo otekanje obraza, žrela, rok, stopal, gležnjev ali spodnjega dela nog
Serious allergic reactions (anaphylaxis)
Resne alergijske reakcije (anafilaksija)
Serious allergic reactions (including potentially fatal anaphylactic shock) which can cause skin rash, swelling of the face, lips, mouth, tongue or throat, wheezing or difficulty breathing; difficulty swallowing
resne alergijske reakcije (vključno z anafilaktičnim šokom, lahko s smrtnim izidom), ki lahko povzročijo izpuščaj na koži, otekanje obraza, ustnic, ust, jezika ali žrela, piskajoče dihanje ali težko dihanje; težave s požiranjem
Serious allergic reactions (including severe localised swelling of the skin and wheezing); lymphoma (a type of blood cancer); melanoma (a type of skin cancer); combined low platelet, red, and white blood cell count; nervous system disorders (with severe muscle weakness and signs and symptoms similar to those of multiple sclerosis or inflammation of the nerves of the eyes or spinal cord); tuberculosis; congestive heart failure; seizures; lupus or lupus-like syndrome (symptoms may include persistent rash, fever, joint pain, and tiredness); low red blood cell count, low white blood cell count, low neutrophil (a type of white blood cell) count; elevated liver blood tests; skin rash, which may lead to severe blistering and peeling of the skin; inflammation of the liver caused by the body's own immune system (autoimmune hepatitis); immune disorder that can affect the lungs, skin and lymph nodes (sarcoidosis).
Resne alergijske reakcije (vključno s hudim lokaliziranim otekanjem kože in piskajočim dihanjem); limfom (vrsta krvnega raka); melanom (vrsta kožnega raka); kombinacija znižanja števila trombocitov in rdečih ter belih krvnih celic; motnje živčevja (s hudo mišično oslabelostjo ter z znaki in s simptomi, podobnimi multipli sklerozi ali vnetje očesnih živcev ali hrbtenjače); tuberkuloza; kongestivno srčno popuščanje; epileptični napadi; lupus ali lupusu podoben sindrom (med simptomi so lahko trdovraten izpuščaj, vročina, bolečine v sklepih in utrujenost); nizko število rdečih krvnih celic, nizko število belih krvnih celic; nizko število nevtrofilcev (vrste belih krvnih celic); povišane vrednosti jetrnih encimov pri krvnih preiskavah; kožni izpuščaj, ki lahko povzroči močno mehurjenje in luščenje kože; vnetje jeter, ki je posledica delovanja imunskega sistema proti tkivu lastnega telesa (avtoimunski hepatitis); imunska bolezen, ki lahko prizadene pljuča, kožo in bezgavke (sarkoidoza).
Serious allergic reactions (rare: may affect up to 1 in 1,000 people): Hypersensitivity reactions, so-called anaphylactic reactions, anaphylactic shock and angioedema.
Resne alergijske reakcije (redke; pojavijo se lahko pri največ 1 od 1.000 bolnikov): preobčutljivostne reakcije, imenovane anafilaktične reakcije, anafilaktični šok in angioedem.
Serious allergic reactions (‘anaphylaxis’) are rare in people taking Stelara (may affect up to 1 in 1,000 people).
Hude alergijske reakcije (‘anafilaksija’) so pri bolnikih, ki jemljejo zdravilo Stelara, redke (pojavijo se lahko pri največ 1 od 1.000 bolnikov).
Serious allergic reactions are uncommon.
Resne alergijske reakcije se pojavijo občasno.
Serious allergic reactions associated with Humira were rare during clinical trials.
V kliničnih študijah so bile redke resne alergijske reakcije, povezane z zdravilom Humira.
Serious allergic reactions have occurred in patients receiving this medicine (see section “4.
Pri bolnikih, ki so dobivali to zdravilo, so se pojavile resne alergijske reakcije (glejte poglavje "4.
Serious allergic reactions including swelling of the face, tongue or throat, trouble swallowing or breathing, suddenly feeling fast pulse or sweating and itchy skin or rash.
resne alergijske reakcije, vključno z otekanjem obraza, jezika ali žrela, oteženo požiranje ali
Serious allergic reactions including swelling, mainly of the face and throat.
Resne alergijske reakcije vključno z otekanjem, predvsem obraza in grla oziroma žrela.
Serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
resne alergijske reakcije, kot je reakcija na zdravilo z eozinofilijo in sistemskimi simptomi (DRESS - Drug Reaction with Eosinophilia and Systemic Symptoms).
Serious allergic reactions that can cause peeling of the skin
resne alergijske reakcije, ki lahko povzročijo luščenje kože,
Serious allergic reactions will need emergency treatment.
Hude alergijske reakcije je treba zdraviti takoj.
Serious allergic reactions with symptoms such as rash, itching, swelling, hives, shortness of breath, fast heart beat and drop in blood pressure;
resne alergijske reakcije s simptomi, kot so izpuščaj, srbenje, otekanje, koprivnica, zasoplost, hitro bitje srca in padec krvnega tlaka,
Serious allergic reactions, anaphylactic shock, anaphylaxis
resne alergijske reakcije, anafilaktičn šok, anafilaksija
Serious allergic reactions, anaphylactic shock, anaphylaxis
resne alergijske reakcije, anafilaktični šok, anafilaksija
Serious allergic reactions, including anaphylaxis can occur in patients receiving Neulasta (uncommon) (see section 4.4).
Bolnikom, ki prejemajo zdravilo Neulasta, se lahko pojavijo resne alergijske reakcije, vključno z anafilaksijo (občasno) (glejte poglavje 4.4).
Serious allergic skin reaction (Stevens-Johnson syndrome or Lyell syndrome).
obstrukcija črevesja hude alergijske kožne reakcije (Stevens-Johnsonov sindrom ali Lyellov sindrom)
Serious allergic/anaphylactic reactions (including angioedema, bronchospasm), sarcoidosis
Redki: resne alergijske/anafilaktične reakcije (vključno z angioedemom in bronhospazmom), sarkoidoza
Serious anaphylaxis/anaphylactoid reactions1
resne anafilaksijske/anafilaktoidne reakcije1
Serious and grade ≥ 3 adverse reactions (such as ALT increased, AST increased, and blood bilirubin increased) were observed in 2.1% and 15.3% of patients respectively.
Resni neželeni učinki (kot so zvišanje ALT, zvišanje AST in zvišanje bilirubina v krvi) so se pojavili pri 2,1 % bolnikov, takšni neželeni učinki ≥ 3. stopnje pa pri 15,3 % bolnikov.
Serious and grade ≥ 3 neurologic adverse reactions were observed in 16.4% and 12.7% of patients respectively, of which the most common were encephalopathy, tremor, and confusional state.
Resne nevrološke neželene učinke so zabeležili pri 16,4 % bolnikov, nevrološke neželene učinke ≥ 3. stopnje pa pri 12,7 % bolnikov; najpogostejši so bili encefalopatija, tremor in stanje zmedenosti.
Serious and sometimes fatal viral, bacterial, protozoan, and fungal infections, including those due to reactivation of latent infections, have been reported in non-MS patients treated with alemtuzumab at higher and more frequent doses than used in MS.
Pri bolnikih, ki niso imeli MS in so bili zdravljeni z alemtuzumabom v večjih in pogostejših odmerkih, kot se uporabljajo za zdravljenje MS, so ugotovili resne in v nekaterih primerih smrtne okužbe z virusi, bakterijami, protozoji in glivami, vključno z reaktivacijo latentnih okužb.
Serious angioedema may occur rarely (≥1/10,000 to <1/1,000).
Redko se lahko pojavi resen angioedem (≥1/10.000 do <1/1.000).
Serious asthma-related adverse events and exacerbations may occur during treatment with Aerivio Spiromax.
Med zdravljenjem z zdravilom Aerivio Spiromax se lahko pojavijo resni, z astmo povezani neželeni učinki ali poslabšanja.
Serious asthma-related adverse events and exacerbations may occur during treatment with Aerivio Spiromax.
Med zdravljenjem z zdravilom Airexar Spiromax se lahko pojavijo resni, z astmo povezani neželeni učinki ali poslabšanja.
Serious asthma-related adverse reactions and exacerbations may occur during treatment with Budesonide/Formoterol Teva .
Med zdravljenjem z zdravilom Budezonid/formoterol Teva se lahko pojavijo resni neželeni učinki, povezani z astmo, in poslabšanje bolezni.
Serious asthma-related adverse reactions and exacerbations may occur during treatment with Budesonide/Formoterol Teva Pharma B.V..
Med zdravljenjem z zdravilom Budezonid/formoterol Teva Pharma B.V. se lahko pojavijo resni neželeni učinki, povezani z astmo, in poslabšanje bolezni.
Serious asthma-related adverse reactions and exacerbations may occur during treatment with Budesonide/Formoterol Teva.
Med zdravljenjem z zdravilom Budezonid/formoterol Teva se lahko pojavijo resni neželeni učinki, povezani z astmo, in poslabšanje bolezni.
Serious bleeding events during the 28-day study period
Resne krvavitve v 28-dnevnem obdobju študije
Serious bleeding-related adverse drug reactions, some of which lead to a fatal outcome, such as central nervous system (CNS) haemorrhage (2%) and gastrointestinal (GI) haemorrhage (2%), in the context of severe thrombocytopaenia, were reported in patients receiving Dacogen.
Pri bolnikih, ki so prejemali zdravilo Dacogen, so poročali o resnih neželenih učinkih v povezavi s krvavitvami, od katerih so bili nekateri smrtni, na primer krvavitev v centralno živčevje (2%) in gastrointestinalna krvavitev (2%).
Serious blood clotting complications (thromboembolic events) independent of OHSS may be found very rarely (may affect up to 1 in 10,000 people).
Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), neodvisni od OHSS, so zelo redki (pojavijo se lahko pri do 1 bolniku od 10.000).
Serious blood clotting complications (thromboembolic events) independent of OHSS may be found very rarely.
Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), neodvisni od OHSS, so zelo redki.
Serious blood clotting complications (thromboembolic events) usually with severe OHSS are found very rarely.
Hudi zapleti strjevanja krvi (trombembolični dogodki) običajno s hudim OHSS, se pojavijo zelo redko.
Serious blood clotting complications (thromboembolic events), sometimes independent of OHSS, may be found very rarely (may affect up to 1 in 10,000 people).
Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), včasih neodvisni od OHSS, so zelo redki (prizadenejo lahko največ 1 od 10.000 bolnic).
Serious blood clotting problems (thromboembolic events) usually with severe OHSS are found very rarely.
Resni zapleti zaradi krvnih strdkov (trombembolični dogodki), običajno pri hudi OHSS, so zelo redki.
Serious blood infection, which can be fatal.
Resna okužba krvi, ki je lahko usodna.
Serious breathlessness, or sudden worsening breathlessness, possibly with a cough or fever.
Resno težko dihanje ali nenadno poslabšanje težkega dihanja, lahko s spremljajočim kašljem ali zvišano telesno temperaturo.
Serious cardiovascular events, including myocardial infarction, sudden cardiac death, unstable angina pectoris, ventricular arrhythmia, stroke, transient ischemic attacks, chest pain, palpitations and tachycardia, have been reported either post marketing and/or in clinical trials.
V obdobju trženja zdravila in/ali v obdobju kliničnih preskušanj so bili opisani resni srčnožilni dogodki, vključno z miokardnim infarktom, nenadno srčno smrtjo, nestabilno angino pektoris, ventrikularno aritmijo, možgansko kapjo, tranzitorno ishemično atako, bolečinami v prsih, palpitacijami in tahikardijo.